Keywords: Spermine (PubChem CID1103); Spermidine (PubChem CID1102); Biogenic amines; Cytotoxicity; Food safety; Spermine; Spermidine; IC50; NOAEL; LOAEL;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NOAEL; no observed adverse effect level; LOAEL; lowest observed adverse effect level; MRL; minimal risk level; JECFA; joint expert committee on food additives; ATSDR; agency for toxic substances and disease registry; PTWI; provisional tolerable weekly int
Keywords: Alpha linolenic acid; Developmental toxicity; Diacylglycerol oil; Flaxseed oil; Food ingredient; Teratology; AA; arachidonic acid; ALA; alpha-linolenic acid; DAG; diacylglycerol; EPA; eicosapentaenoic acid; FDA; Food and Drug Administration; GD; gestation
Keywords: EPA; Environmental Protection Agency; MAX; maximum stimulatory response in the low-dose zone of a dose-response relationship; NOAEL; no-observed-adverse-effect level derived from a complete dose-response relationship; Antibiotics; Dose-response; Hormesis;
Keywords: ADI; acceptable daily intake; BMI; body mass index; BW; body weight; BP; bisphenol; BP-3; oxybenzone/benzophenone-3; BuP; butyl paraben; DEMOCOPHES; Demonstration of a study to Coordinate and Perform Human biomonitoring on a European Scale; EDCs; endocrin
Keywords: Biotherapeutics; Gene and cell therapy; Pharmacokinetics; Non-clinical safety; Immunogenicity; Cross-reactive species; ATMP; advanced therapy medicinal products; CAR; chimeric antigen receptor; CD; cluster of differentiation; CMC; chemistry manufacturing
Keywords: Endotoxin limit; Regenerative medicine products; Human mesenchymal stem cells; Bone differentiation; LPS; Lipopolysaccharide; FGF; Fibroblast growth factor; BMP; Bone morphogenetic protein; CD; cluster of differentiation; LC-MS/MS; liquid chromatograph-ta
Keywords: ADME; absorption, distribution, metabolism and excretion; AUC; area under the blood/plasma concentration time curve; BMDL; lower 95% confidence limit of the benchmark dose; Cmax; maximum blood/plasma concentration; NOAEL; no-observed-adverse-effect-level;
Keywords: salt; solubility; stability; biopharmaceutical; poorly water soluble; solution phase; solid phase; equilibrium; pKa; pH; AB; acetate buffer; ACN; acetonitrile; API; active pharmaceutical ingredient; BS; benzoate salt; CB; citrate buffer; DSC; differential
Keywords: Mulberry leaf extract; Rat; Subacute toxicity; Genotoxicity; Ames assay; Micronucleus; Sperm abnormality; Safety assessment; 1,8-DHAQ; 1,8-dihydroxyanthraquinone; 2-AF; 2-aminofluorene; 4-NO; 4-nitro-O-phenylenediamine; ALB; albumin; ALP; alkalinephosphat
Keywords: Safety; Evaluation; Genotoxicity; Toxicity; Functional; Food; SFG; steady-fiber granule; NOAEL; no observed adverse effect level; β-NADP; β-nicotinamide adenine dinucleotide phosphate; FDA; Food and Drug Administration; OECD; Organization for Economic C
Keywords: β-HCH; β-hexachlorocyclohexane; µg/l; microgram per liter; µM/l; micromolar per liter; Ʃ; total; 1-HP; 1-hydroxypyrene; 2; 3-DHBA, 2,3-dihydroxybenzoic Acid; 2cx-MMHP; mono-(2-carboxymethylhexyl) phthalate; 3PBA; 3-phenoxybenzoic acid; 4F3PBA; 4-fluo
Keywords: 2D-sw; 2D-sandwich; AMI; amiodarone; APAP; acetaminophen; BA; bile acid; BC; bile canaliculi; BOS; bosentan; BSEP; bile salt export pump; CPZ; chlorpromazine; CSA; cyclosporine A; CYP450; cytochrome P450; DIC; drug-induced cholestasis; DICI; drug-induced
Keywords: Ag; silver; AgNPs; silver nanoparticles; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; b.w.; body weight; BBB; blood-brain-barrier; CMT; Carousel Maze test, active place avoidance test; ENTR; number of entrance
Keywords: Pyrrolizidine alkaloids; Acute toxicants; Genotoxic carcinogens; Hepatotoxic agents; Food; Food supplements; ANZFA; Australia New Zealand Food Authority; acute reference dose; ARfD; DHP; 6,7-dihydro-7-hydroxy-1-hydroxymethyl-5[[H]]-pyrrolizine; BfR; Feder
Keywords: 3βHSD; 3β-hydroxysteroid dehydrogenase; 17βHSD; 17β-hydroxysteroid dehydrogenaseâ; cDNA; complementary DNA; DBP; dibutyl phthalate; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; GD; Gestation day; HMG-CoA reductase; 3-hydroxy-3-methylglutaryl coe
Keywords: Steaming; Seafood; Toxic elements; PFCs; PAHs; Musk fragrances and UV-Filters; 4-MBC; 3-(4-Methylbenzylidene)camphor; AHTN; 7-acetyl-1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydronaphthalene; ANOVA; analysis of variance; AsV; arsenic V; BaP; benzo(a)pyrene; BM
Keywords: 11BHSD; 11β-hydroxysteroid dehydrogenase; ACTH; adrenocorticotropic hormone; AE; adverse event; ALT; alanine aminotransferase; AUC; area under the curve; BMI; body mass index; CBG; cortisol binding globulin; CL/F; apparent total clearance of the drug fro
Keywords: Health risk assessment; Air freshener consumer products; Inhalation and dermal hazard; Fragrance ingredients; Tiered 1 and 2 risk assessment; IAQ; indoor air quality; KME; Korean Ministry of Environment; KNLIC; Korean National Law Information Center; SCCN
Keywords: Risk assessment; NOAEL; Benchmark dose; ECHA; ATSDR; 28-day to 90-day extrapolation; Study duration; Point of departure;
Keywords: ADME; Absorption, Distribution, Metabolism, Excretion; AOPs; adverse outcome pathways; AUC; Area under the Curve; AEs; assessment elements; AOs; assessment options; BMDL; benchmark dose lower bound; CAAT; Center for Alternatives to Animal Testing; Cefic-L
Keywords: Rare earth elements; ADI; Yttrium; Subchronic toxicity; NOAEL;
Keywords: Aspergillus oryzae; Protease; Xylanase; Enzyme; Animal feed; Oral-toxicity study; Genotoxicity study; NOAEL;
Keywords: Benchmark dose modeling; DNA methylation; LINE-1; miRNA; Metabolomics; Hepatotoxicants; Dose-response; Ahr; Aryl Hydrocarbon receptor; BA; Bile Acid; BMD; Benchmark Dose; BrdU; Bromodeoxyuridine; CAR; Constitutive Androgen Receptor; CF; Clofibrate; ChIP;
Keywords: TTC; Developmental toxicity; Rat; Rabbit; NOAEL;
Keywords: Mesoporous silica nanoparticles; Oral drug delivery; Gastrointestinal tract; Core-shell microparticles; Functional foods; Probiotics; BCS; biopharmaceutical classification system; DDS; drug delivery system; DSMs; diatom silica microparticles; DRF; dose ra
Keywords: ACP; acetophenone; AHI; Atmospheric Hazard Index; CAHI; Chemical Atmospheric Hazard Index; CEL; Chemical Exposure Limit; CHP; cumene hydroperoxide; ChV; Chronic concentration Value; CRSI; Chemical Route Safety Index; CTHI; Chemical Terrestrial Hazard Inde
Keywords: Cumulative acute exposure; Probabilistic method; Organophosphorus pesticides; Effect of LOQ and zero residues; EFSA; European Food Safety Authority; LOQ; limit of quantification; LOR; limit of reporting; OP; organophosphates; RPF; relative potency factor;
Keywords: Honokiol microemulsion; Cerebral ischemia protection; Embryo-fetal development toxicity; AAALAC; Association for Assessment and Accreditation of Laboratory Animal Care; GD; gestation day; GLP; Good Laboratory Practice; ICH; International Conference on Har
Keywords: AChE; acetylcholinesterase; ADI; acceptable daily intake; ALAT; alanine aminotransferase; ASAT; aspartate aminotransferase; BChE; butyrylcholinesterase; CPF; chlorpyrifos; ED; endocrine disruptor; E2; estradiol; ERα; estrogen receptor alpha; FSH; follicl
Keywords: Pyrrolizidine; Echimidine; Lasiocarpine; bw; bodyweight; d; day; NOAEL; No Observed Adverse Effect Level; NTP; National Toxicology Program; PA; pyrrolizidine alkaloid; TBHQ; tert-butylhydroquinone;
Keywords: Palm tocotrienols; Palm carotenes; Vascular function; Flow-mediated dilation; AI; augmentation index; BMI; body mass index; CTAB; citrate, theophylline, adenosine and dipyridamole; CV; coefficient of variance; CVD; cardiovascular disease; EFSA; European F
Keywords: DEHP; Di(2-ethylhexyl) phthalate; CNS; central nervous system; E; embryonic day; P; postnatal day; PLP; periodate lysin paraformaldehyde; PBS; phosphate-buffered saline; Tuj1; neural class III β-tubulin; BrdU; bromo-deoxyuridine; CldU; chloro-deoxyuridin
Keywords: 2D; two dimensional; 3D; three dimensional; ATP; adenosine triphosphate; BALF; bronoalveolar lavage fluid; CA; chromosome aberration; CB; conduction band; CHO; Chinese hamster ovary; CNT; carbon nanotubed; DEPMPO; 5-diethoxyphosphoryl-5-methyl-1-pyrroline
Keywords: Risk assessment; Less than lifetime exposure; Fluctuating exposure; Intermittent exposure; ADME; absorption, distribution, metabolism and excretion; AUC; area under the blood/plasma concentration time curve; BMDL; lower 95% confidence limit of the benchma
Keywords: Windows of sensitivity; Motor development; Chemical exposures; Laboratory animals; GD; gestation day; LOAEL; lowest observed adverse effect level; NOAEL; no observed adverse effect level; PND; post-natal day; PNM; post-natal month; PNW; post-natal week;
Keywords: Allergy; Dose distribution; Modelling; Sesame; Threshold; DBPCFC; Double Blind Placebo Controlled Food Challenge test; ED; Eliciting Dose; EU; European Union; LOAEL; Lowest Observed Adverse Effect Level; NOAEL; No Observed Adverse Effect Level;
Keywords: Triclosan; Exposure; Reproductive endocrine-disruption; Steroidogenesis; Hormone receptor; TCS; triclosan; EDCs; endocrine-disrupting chemicals; PCPs; personal care products; NOAEL; no observed adverse effect level; NHANES; national health and nutrition e
Keywords: 2-AA; 2-aminoanthracene; 2-NF; 2-nitrofluorene; 9-AA; 9-aminoacridine; ARA; arachidonic acid; bw; body weight; CBPI; cytokinesis-blocked proliferation index; DHA; docosahexaenoic acid; DMSO; dimethyl sulfoxide; F1; first generation; FOB; functional observ
Keywords: Antioxidant enzymes; Brain; Inflammation; Nanoparticles; Oxidative stress; Renin-angiotensin system; ACTB; beta actin; APP; amyloid β (A4) precursor protein; APx; ascorbic acid peroxidase; ARO; aromatase; ANG; angiotensin; ACE; angiotensin converting e
Keywords: MoA; mode of action; HPT; hypothalamic pituitary thyroid; UGT; uridine diphosphate glucuronosyltransferase; NOAEL; no observed adverse effect level; CAR; Constitutive Androstane Receptor; PCBs; polychlorinated biphenyls; USEPA; United States Environmental
Keywords: Al; Aluminum; Sb2O3; Antimony trioxide; BP; Benzophenone; BPA; Bisphenol-A; Ce; Cerium; DCC; Dextran-coated charcoal; DIDP; Di-isodecylphthalate; DINP; Di-isononylphthalates; DMSO; Dimethyl sulfoxide; MTT; 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-tetrazo
Keywords: Benzophenone; Ethylhexyl Methoxycinnamate; Butyl Methoxydibenzoylmethane; Dermal permeation; Systemic Exposure Dosage; Margin of Safety; AD; applied dose (sunscreen); BMDBM; Butyl Methoxydibenzoylmethane; BP3; Benzophenone-3; CID; compound identifier; EC;
Keywords: SHetA2; N-(2,3-dihydro-2,2,4,4-tetramethyl-6-benzothiopyranyl), Nâ²-(4-nitrophenyl)thiourea; ATRA; all trans retinoic acid; NOAEL; no observed adverse effect level; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MTS; MTT coupled with
Keywords: EDCs; endocrine disrupting chemicals; PCBs; polychlorinated biphenyls; PAHs; polyaromatic hydrocarbons; BFRs; brominated flame retardants; Aps; alkylphenols; PFCs; perfluorinated chemicals; POPs; persistent organic pollutants; ER; estrogen receptor; NOAEL
Keywords: ADA; Anti-drug antibody(ies); ADCC; Antibody-dependent cellular cytotoxicity; AE; Adverse event; CBA; Cell-based assay; CDC; Complement dependent cytotoxicity; CLB; Competitive ligand binding; EIP; European Immunogenicity Platform; EIP-AWG; European Immun
Keywords: BPA; bisphenol A; BMD; benchmark dose; BMI; body mass index; DEHP; di(2-ethylhexyl) phthalate; DHEA-S; dehydroepiandrosterone sulfate; DES; diethylstilbestrol; DTT; 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane; EDC; endocrine disrupting chemicals; EDSTA
Keywords: Pyrrolizidine alkaloids; Risk assessment; Herbals; Margin of exposure; Herbal medicinal products; Safety; Carcinogenicity; Mutagenicity; ANZFA; The Australia New Zealand Food Authority; BfR; Federal Institute for Risk Assessment; BMDL10; benchmark dose lo
Keywords: As; arsenic; BMI; body mass index; BSID; Bayley Scales of Infant Development; Cal-EPA; California Environmental Protection Agency; CAT; Cognitive Abilities Test; CI; confidence interval; CVLTC; California Verbal Learning Test-Children; DMA; dimethylarseni
Keywords: BMD; benchmark dose; BMDL; lower confidence bound of the benchmark dose; NOAEL; no observed adverse effect level; LOAEL; lowest observed adverse effect level; EFSA; European Food Safety Authority; OECD; Organisation for Economic Co-operation and Developme